5 things to know about what’s new in hemophilia
From new longer-acting drugs to promising gene therapy trials, much is changing in the treatment of hemophilia, the inherited bleeding disorder in which the blood does not clot. I will mark Hemophilia Awareness Month by discussing research and treatment progress, as well as remaining challenges.
1. Many more treatment products are being introduced, including some that last longer. In people with hemophilia, a “factor” — or blood …